Upcoming Events

There are no upcoming events at this time.

Register Today!

Get Free Test Access

New Article in ACT

New Article in ACT

ACTIn Applied Clinical Trials journal appeared an article, which investigates the question of site screening due diligence and how it can improve patient dropout rates – “RbM Data Reveals Site Screening Due Diligence Improves Patient Dropout and Retention”. The investigations for the article were done applying the Cyntegrity’s RbM System EarlyBird®.

Read more here:


Cyntegrity is happy to support researchers in this field with technology and information.

Are you a young researcher in the area clinical risk management and RbM and would like to get Cyntegrity’s support for your research project?

Contact Us

By | 2016-11-16T18:35:47+00:00 March 19, 2015|News|0 Comments

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Leave A Comment